MLB: Phillies C J.T. Realmuto activated from IL

Date:

Share post:


The Philadelphia Phillies reinstated star catcher J.T. Realmuto from the 10-day injured list on Saturday.

Realmuto, a three-time All-Star, has been sidelined since mid-June following right meniscus surgery.

Also on Saturday, the Phillies recalled right-hander Yunior Marte from Lehigh Valley and optioned catcher Rafael Marchan and righty Michael Mercado to the Triple-A team.

Realmuto, who was placed on the 10-day IL on June 11 (retroactive to June 10), is batting .261 with seven homers and 20 RBIs in 51 games this season. He had hit in a career-best 17 straight games in which he played earlier this season.

Realmuto, 33, is a career .272 hitter with 161 homers and 598 RBIs in 1,191 games with the Miami Marlins (2014-18) and Phillies.

Marte, 29, posted a 3.31 ERA in 15 relief appearances with Philadelphia this season. He is 2-2 with two saves and a 4.95 ERA in 94 career relief appearances with the Phillies.

Marchan, 25, batted .294 with three homers and six RBIs in 17 games with the Phillies this season.

Mercado, 25, posted a 1-2 record with a 9.26 ERA in four appearances (two starts) with Philadelphia this season.

–Field Level Media

spot_img

Related articles

MLB: Mets RHP Paul Blackburn has spinal procedure, out 4-5 months

New York Mets right-hander Paul Blackburn underwent a procedure to repair a cerebrospinal fluid leak earlier this month...

MLB: Displaying Dodgers DH Shohei Ohtani’s dominance in 17 startling statistics

Los Angeles Dodgers designated hitter Shohei Ohtani decided six years ago he was heading to the United States...

MLB: Nestor Cortes likely for Yankees roster; Gerrit Cole to start G1

The New York Yankees expect to have left-hander Nestor Cortes on the roster when the World Series begins...

MLB: Experienced Dodgers favored to sink Yanks in World Series

Getting to the World Series has seemingly become second nature for the Los Angeles Dodgers. With Sunday night's...

FREE

Get the most important breaking news and analyses for Free.

Thank you for subscribing

Something went wrong.